Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers September 20, 2017
Pharmacy Choice - News - Front Page Healthcare News - September 20, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

9/13/17 - "Modernizing FDA's Regulation of Over-the-Counter Drugs."
FDA regulates most of the drugs on drug store shelves under the "OTC monograph system," though manufacturers do have the option to file a new drug application in lieu of using the OTC monograph system for OTC products. FDA publishes monographs that provide a rulebook for marketing safe and effective products containing particular active ingredients
9/13/17 - "Simply having coverage is not enough. It must be affordable and the quality of the health care, including protections for patients, cannot be compromised."
WASHINGTON- U.S. Senator Ben Cardin, a member of the Senate Finance Health Care Subcommittee, has continued his call for Congress to work in a bipartisan way to improve upon the landmark Patient Protection and Affordable Care Act, solidifying the truth that affordable, quality health care is a right and not a privilege that all Americans should hav
9/13/17 - 3,500 Job Cuts at Eli Lilly Signal Change in Focus [Tehran Times (Iran)]
The move will free up about $500 million which the company plans to use to fund clinical development of the drugs in its pipeline. We have an abundance of opportunitieseight medicines launched in the past four years and the potential for two more by the end of next year, said David A. Ricks, Lilly`s chairman and chief executive officer. As part of
9/13/17 - AAC Holdings to Increase Payor and Geographic Diversification with Agreement to Acquire AdCare in New England
AAC Holdings, Inc. announced today that it has reached a definitive agreement to acquire AdCare, Inc., its affiliates and associated real estate assets for total consideration of $85 million. AdCare, founded in 1986, is one of the leading providers of addiction treatment in New England with over 6,000 hospital and residential admissions and over
9/13/17 - AARP Applauds Congress for Bipartisan Hearings on Stabilizing The Health Insurance Market
AARP issued the following news release:. AARP submitted written testimony today to the U.S. Senate Committee on Finance and the U.S. Senate Committee on Health, Education, Labor and Pensions, urging Congress to focus on commonsense solutions to stabilize the Affordable Care Act insurance marketplace, increase enrollment and competition, and lower c
9/13/17 - AbbVie's Upadacitinib Meets All Primary and Ranked Secondary Endpoints in Second Phase 3 Study in Rheumatoid Arthritis
Release date- 12092017- NORTH CHICAGO, Ill.- AbbVie, a global research and development based biopharmaceutical company, today announced positive top-line results from the Phase 3 SELECT-BEYOND clinical trial evaluating upadacitinib, an investigational oral JAK1-selective inhibitor, in patients with moderate to severe rheumatoid arthritis who did no
9/13/17 - Absolute Analysis on mHealth Market: Worth USD 21.71Billion by 2022, at CAGR of 36.5%
"mHealth Market" mHealth Market Information, By Therapeutics By Application- Forecast to 2022. Market Research Future published a research report on "mHealth Market Research Report- Global Forecast To 2022"- Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022. Market Synopsis of MHealth Market:.
9/13/17 - AccentCare Expands Use of Sandata Electronic Visit Verification Solution Nationwide
AccentCare has deployed Sandata's EVV solution in its New York locations since 2011 to help create operational efficiencies, support visit management, and enhance the delivery of quality care. "We are honored to have a longstanding relationship with a forward-thinking organization like AccentCare," said Tom Underwood, Sandata's CEO. Mike Brown, Ch
9/13/17 - Achillion Announces Strengthening of Management Team
Prior to that, Dr. Ingerman served as Vice President of Ophthalmology at Regeneron Pharmaceuticals where he was responsible for the Eylea development program, conducted in collaboration with Bayer Healthcare. Prior to his tenure at Regeneron, Dr. Ingerman was research and development director in Israel and the UK, and clinical leader for the Lastac
9/13/17 - Achillion Announces Termination of Worldwide Collaboration for Hepatitis C with Janssen
Release date- 12092017- NEW HAVEN, Conn.- Achillion Pharmaceuticals, Inc. announced today that on Saturday, September 9, 2017, it received notice of termination of the worldwide license and collaboration arrangement on hepatitis C with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson& Johnson. 'We are disappoint
9/13/17 - Addivant(TM) Receives Formal Approval From the FDA for Food Contact Use of Its Nonylphenol-Free Antioxidant Weston 705 in Styrene Block Polymers
DANBURY, Conn., Sept. 13, 2017 Addivant (TM), the world leading supplier of liquid phosphite antioxidants for plastics, announced today that its nonylphenol-free stabilizer, WESTON 705, has received formal approval from the US Food and Drug Administration for food contact use in styrene block polymers. This expands the food contact use of WEST
9/13/17 - Addivant? Receives Formal Approval From the FDA for Food Contact Use of Its Nonylphenol-Free Antioxidant Weston 705 in Styrene Block Polymers
DANBURY, Conn., 2017-09-13 14:42 CEST Addivant?, the world leading supplier of liquid phosphite antioxidants for plastics, announced today that its nonylphenol-free stabilizer, WESTON 705, has received formal approval from the US Food and Drug Administration for food contact use in styrene block polymers.. This expands the food contact use o
9/13/17 - Admera Health Expands Asian Footprint with Three Strategic Partnerships [Sudan Tribune]
-Today, Admera Health announced agreements expanding Admeras portfolio of molecular diagnostics to Asia, including but not limited to Singapore, Hong Kong, Korea and Taiwan. Admera Health, a molecular diagnostic company, offers the most comprehensive pharmacogenomics testing services available, its PGxOne Plus test interrogates 50 genes with covera
9/13/17 - Africa Medical Devices Market 2017 Regional Outlook, Growing Demand, Analysis, Size, Share and Forecast to 2023
Africa presents both opportunities and challenges which are very different from the rest of world. It is estimated that 62% of the population in Africa is under 25 years as compared to Europe whose workforce is expected to shrink from 63% in 2010 to 51% in 2050. Thus the company which will dominate the market first will have a stranglehold on the m
9/13/17 - Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay
Agilent Technologies Inc. has announced that it has obtained 510 clearance from the U.S. Food and Drug Administration for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization assay for diagnostic use. Previously available only in Europe, U.S. clinical genetic scientists can now use this assay to help identify a definitive
9/13/17 - Akcea Announces Filing of New Drug Submission for Volanesorsen to Health Canada [T-break Tech (Middle East)]
This decision underscores the significant medical need that exists for Canadians suffering with FCS, a disease characterized by severe chronic and daily symptoms, including the risk of potentially fatal episodes of acute pancreatitis. The evidence of the potential for volanesorsen to benefit individuals with FCS began with a Phase 2 study in Canada
9/13/17 - Allergan transfers patents to Mohawk Tribe Allergan assigns Restasis patents to Saint Regis Mohawk Tribe in bid to keep monopoly
Allergan has transferred its patents on the drug, used to treat dry eyes, to the Saint Regis Mohawk Tribe in upstate New York, according to an Allergan press release. Allergan has exclusive license in the drug's patents and will pay the tribe $13.75 million upfront, then up to $15 million annually in royalties. "This is really a novel way of tryin
9/13/17 - Allergy Diagnostics Market 2017 by Products, Allergens, Tests, End Users - Global Forecast to 2022 - Research and Markets
The "Allergy Diagnostics Market by Products, Allergens, Tests, End Users- Global Forecast to 2022" report has been added to Research and Markets' offering. The global allergy diagnostics market is expected to reach USD 5.74 Billion by 2022 from USD 3.49 Billion in 2017, at a CAGR of 10.5%. The major factors driving this market are the high incidenc
9/13/17 - Alligator Bioscience Signs Immunotherapy Research Collaboration Agreement for 4-1BB
Alligator Bioscience, a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that a research collaboration agreement has been signed with Professor Ignacio Melero, MD, PhD, Center for Applied Medical Research and Clnica Universidad de Navarra, Spain, to further investigate the biology..
9/13/17 - Amicus Therapeutics Announces Top-Line Phase 3 Results for SD-101 in Epidermolysis Bullosa
Amicus Therapeutics, Inc. reported that top-line data from the randomized, double-blind, placebo-controlled Phase 3 clinical study to assess the efficacy and safety of the novel topical wound-healing agent SD-101 did not meet the primary endpoints or secondary endpoints in participants with epidermolysis bullosa. The Phase 3 ESSENCE study randomi
9/13/17 - Analogics CT Checkpoint Screening Solution, ConneCT, Achieves US TSA Certification [Arab Times (Kuwait)]
-Analogic Corporation, enabling the world`s medical imaging and aviation security technology, today announced that its next-generation CT screening solution for airport checkpoints, ConneCT, has achieved U.S. Transportation Security Administration Certification per the Advanced Technology detection standards. This milestone makes ConneCT...
9/13/17 - Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG806 [Syrian Arab News Agency]
-Aptose Biosciences Inc., a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today announced that the United States Patent and Trademark Office has issued US Patent 9,758,508 entitled 2,3- DIHYDRO-ISOINDOLE-1-ON DERIVATIVE AS BTK KINASE SUPPRESSANT, AND PHARMACEUTICAL...
9/13/17 - Astellas, KMPH, SRNE To Face FDA, ALXN Trims Workforce, ALDX Soars On Trial Data
TOKYO- Today's Daily Dose brings you news about regulatory catalysts awaiting Astellas, KemPharm and Sorrento; Aldeyra's positive phase IIa clinical trial results in dry eye disease; Inotek's merger with Rocket Pharmaceuticals and Zafgen's progress in phase II trial of ZGN-1061 in type 2 diabetes. Astellas Pharma Inc.' s supplemental New Drug Appli
9/13/17 - Auto-Injectors Market Is Expected to Grow with CAGR of 17.2% from 2017 to 2022 Foresight Research
Global Auto-Injectors Market Information, By Product Type, By Application, By Suppliers- Forecast Till 2022 Pune, India 09/13/2017 Market Highlights Auto injector market is expected to grow with CAGR of 17.2% from 2016 to 2022, Is Expected to Increase by USD 2.9 Billion by the End of 2022 Auto injector is defined as a medical device designed
9/13/17 - AVEO Oncology Announces Receipt of Payments from EUSA Pharma and CANbridge
AVEO Oncology today announced the receipt of a $4 million research and development payment from EUSA Pharma related to the approval of FOTIVDA for the treatment of adult patients with advanced renal cell carcinoma in Europe, and a $0.5 million milestone payment from CANbridge related to manufacturing development activities for AV-203, AVEO s.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement